Health · Pan-African
African Medicines Agency Moves Into New Phase as AU Targets 60% Local Supply by 2040
The African Medicines Agency has set up seven technical committees and two industry-focused hubs in Kigali as the African Union pursues a goal of locally meeting at least 60% of Africa's medical product needs by 2040, against heavy reliance on imported medicines and vaccines.
The African Medicines Agency (AMA), created by the African Union, has entered a new phase of its rollout in Kigali, Rwanda, as the continent seeks to produce more of the medicines and vaccines it needs.
The agency, which has been operational since 2025, has inaugurated seven technical committees designed to strengthen its scientific expertise. Its mission is to bring national regulations closer together and harmonise them, improving oversight of medicines and other medical products across the continent.
Michel Sidibé, the African Union's special envoy to the AMA, described the agency as a necessity. He said the new expert committee, drawing on specialists from across Africa, would help reinforce the capacity of national regulatory authorities.
During the week dedicated to the agency, two hubs were also launched to link regulators with industry. The first is meant to support manufacturers wishing to expand their activities in Africa, while the second focuses on cooperation and skills development. The aim is to help companies meet regulatory requirements and prepare products for African markets.
AMA expert Solomon Onen of Uganda said the manufacturing hub would identify the support and capacity-building needs of industrial players. The capacity-building hub would then draw on existing African expertise, working with AMA partners including the World Health Organization, the European Medicines Agency, universities and regional centres of excellence.
The initiative responds to heavy import dependence. According to the United Nations, Africa imports between 70% and 90% of its pharmaceutical products, at an estimated cost of US$14.5 billion. Local production is said to cover only about 1% of the continent's vaccine needs.
The African Union aims to meet at least 60% of Africa's medical product needs locally by 2040. The source notes that reaching this goal will require more than new production units, including investment in skills, quality, regulation and markets able to sustain African manufacturers over the long term.